The CAG, which is the country’s supreme audit body, has submitted over a dozen audit reports to the Lieutenant-Governor of ...

Avidity Biosciences specializes in RNA-based therapies using Antibody-oligonucleotide conjugates to deliver drugs directly to ...

Pulse Biosciences, Inc. (Nasdaq: PLSE) , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans to present at the ...

Former Speaker of the Lagos State House of Assembly Mudashiru Obasa has vehemently denied allegations that the Department of ...

The Department of State Services (DSS) has threatened legal action against two major Nigerian broadcast stations, Africa ...

President John Dramani Mahama has underscored the importance of reparatory justice for Africans and people of African descent ...

STARKVILLE, Miss.—Mississippi State Assistant Professor of Biomedical Engineering Amirtahà Taebi is a Rising Star of ...

A wide pulse pressure is when the difference between the top number (systolic) and bottom number (diastolic) of your blood pressure reading is more than 100 millimeters of mercury (mm Hg) apart. It is ...

The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.

Pulse Biosciences, Inc.’s PLSE share price has dipped by 11.28%, which has investors questioning if this is right time to buy.

Mr. Skinner brings a wealth of experience to Pulse Biosciences, having most recently served as Vice President, FP&A and Investor Relations at Copeland, a private equity-backed industrial company.